MediWound Ltd. (MDWD) Financials

MDWD Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 80.0 million 38.6 million
Dec. 31, 2025 86.3 million 34.3 million
Sept. 30, 2025 94.4 million 44.3 million
June 30, 2025 67.0 million 46.9 million

MDWD Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -8.6 million 644000
Dec. 31, 2025 -5.2 million 662000
Sept. 30, 2025 -3.7 million 740000
June 30, 2025 -6.8 million 862000

MDWD Net Income

No data available :(

MDWD Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 44.6 million - 8.1 million
Dec. 31, 2025 53.1 million - 8.2 million
Sept. 30, 2025 59.1 million 8.3 million 8.3 million
June 30, 2025 32.4 million - 8.1 million

MDWD Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 12.9 million
Dec. 31, 2025 12.8 million
Sept. 30, 2025 11.0 million
June 30, 2025 10.8 million

MDWD Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 1.8 million 5.2 million 3.6 million 1.3 million
Dec. 31, 2025 2.5 million 4.5 million 3.3 million -516000
Sept. 30, 2025 1.1 million 3.5 million 4.0 million 1.6 million
June 30, 2025 1.0 million 3.5 million 3.6 million 1.5 million

MDWD Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 1.5 million 1.2 million
Dec. 31, 2025 1.9 million 1.6 million
Sept. 30, 2025 5.4 million 4.5 million
June 30, 2025 5.7 million 4.4 million

MDWD

Price: $14.42

52 week price:
13.54
21.26

Earnings Per Share: -2.26 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: Israel

Volume: 65559

Ebitda: -2.6 million

Market Capitalization: 162.3 million

Links: